Listen: FDA turmoil, election intrigue, AI, and more
A STAT podcast episode covers current biotech headlines including FDA turmoil, M&A, AI and election effects. Topics discussed include the FDA's refusal to review Moderna's mRNA flu vaccine, GLP-1 outlook, a failed Grail cancer-detection study, Hims fallout, and broader market and regulatory moves.
Why it mattersFDA's refusal to review Moderna's mRNA flu vaccine raises regulatory risk.
Entities Mentioned
ModernaGrailHims
People Mentioned
Jared Holz